Archive · 28 Jul 2025
Akums Receives Certification to Expand LatAm Exports
Akums, a large Indian pharmaceutical company, received a GMP certification from Brazil's health agency (Anvisa) for its factory in Haridwar.
This allows Akums' partners to make more medicine for Brazil and other Latin American countries.
It also helps them get their products approved and sold more quickly in these areas.
Sanjeev Jain, the MD of Akums, said this is good for growing their business in Latin America.
Akums Drugs & Pharmaceuticals received GMP certification for its Haridwar plant.
The certification enables partners to increase production in Brazil and Latin America.
Sanjeev Jain, MD of Akums, confirmed the certification's impact.
This certification enables faster product registrations in the region.
The GMP certificate was granted by the Brazilian Health Regulatory Agency (Anvisa).
- Who
- Akums Drugs & Pharmaceuticals.
- What
- Akums received GMP certification.
- When
- July 28, 2025 (publication date).
- Where
- Haridwar, India (plant location) and Brazil and Latin America (markets).
- Why
- To boost exports and commercialization in Brazil and Latin America.
- Company
- Akums Drugs & Pharmaceuticals
- Certification Received From
- Anvisa (Brazilian Health Regulatory Agency)
- Facility Location
- Haridwar, India
- Purpose
- To boost exports
- Target Market
- Brazil and Latin America
- Key Personnel
- Sanjeev Jain (MD - Akums)